DIN 02539934 — SOGROYA 5 MG
SOGROYA is a solution of Somapacitan marketed by NOVO NORDISK CANADA INC. The full Somapacitan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02539934
- Brand name
- SOGROYA
- Active ingredient
- Somapacitan
- Strength
- 5 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting human growth hormone (GH) analogue
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Somapacitan products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02539942 | SOGROYA | 10 MG | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02539950 | SOGROYA | 15 MG | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |